AiXin Life International, Inc. (AIXN) Stock

About AiXin Life International, Inc.

AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.

AiXin Life International, Inc. is headquartered in CN.

AiXin Life International, Inc. (AIXN) stock trades at $0.26 with a market capitalization of $6.50M. The stock is valued at a price-to-earnings (P/E) ratio of -3.18, price-to-book of -0.99, price-to-sales of 4.36. Over the past 52 weeks the stock has ranged between $0.10 and $0.68, and currently trades 61.8% below its 52-week high.

On profitability, AiXin Life International, Inc. generates a return on equity (ROE) of 35.72% — well above the market average, a sign of a high-quality business, return on capital employed of 47.63%, an operating margin of -169.23%, a net profit margin of -137.13%.

Official website: www.aixinjituan.com